Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,General Medicine
Reference16 articles.
1. Hernandez-Milian A, Payeras-Cifre A. What is new in listeriosis? Biomed Res Int. 2014;2014:358051. doi: 10.1155/2014/358051 .
2. Maertens De NC, Devleesschauwer B, Angulo FJ, et al. The global burden of listeriosis: a systematic review and meta-analysis. Lancet Infect Dis. 14:1073–82.
3. Uppsala Monitoring Centre. VigiBase, the World Health Organization (WHO) international database of suspected adverse drug reactions. https://www.who-umc.org/vigibase/vigibase/ . Accessed 3 Mar 2017.
4. Rau D, Lang M, Harth A, et al. Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis--Report of Two Cases. Int J Mol Sci. 2015;16:14669–76.
5. Wray S. A descriptive analysis of infectious adverse reactions in alemtuzmab-treated multiple asclerosuis patients. Abstract (poster 812), 25th congress of the European Committeee for Treatment and Research, September 9–12 2009 Dusseldorf, Germany
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献